Notwithstanding, our findings are consistent with other research supporting an anti-proliferative role of IFIT3 in cancer [42], as we demonstrate a new role for the αvβ6 integrin as a negative regulator of IFIT3. This evidence concerns the gene IFIT3 and cancer.